{"transactions":[{"id":743037,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:39:38.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":433837,"source":{"system":"sec-edgar","filing":"0001628280-26-042132","document":"wk-form4_1781113175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042132/wk-form4_1781113175.xml","form_type":"4"}},{"id":788726,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2026-05-07T23:03:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":6040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":6040,"derivative":{"exercise_price":65.87,"expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":6040},"source":{"system":"sec-edgar","filing":"0001159036-26-000062","document":"wk-form4_1778195020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000062/wk-form4_1778195020.xml","form_type":"4"}},{"id":788725,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T23:03:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director."}],"balance_after":4685,"source":{"system":"sec-edgar","filing":"0001159036-26-000062","document":"wk-form4_1778195020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000062/wk-form4_1778195020.xml","form_type":"4"}},{"id":941837,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:00:32.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":330500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029."}],"balance_after":330500,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":330500},"source":{"system":"sec-edgar","filing":"0001520138-26-000017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000017/ownership.xml","form_type":"4"}},{"id":941836,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-09T22:00:32.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting."}],"balance_after":90000,"derivative":{"exercise_price":1.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001520138-26-000017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013826000017/ownership.xml","form_type":"4"}},{"id":947552,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2026-01-06T23:56:43.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a stock options granted under the Issuer director compensation program.  This grant will vest in full on the date of the Issuer 2026 annual meeting of stockholders."}],"balance_after":1342,"derivative":{"exercise_price":70.31,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1342},"source":{"system":"sec-edgar","filing":"0001159036-26-000007","document":"wk-form4_1767743799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000007/wk-form4_1767743799.xml","form_type":"4"}},{"id":947551,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-06T23:56:43.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the date of the Issuer's 2026 annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director."}],"balance_after":889,"source":{"system":"sec-edgar","filing":"0001159036-26-000007","document":"wk-form4_1767743799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000007/wk-form4_1767743799.xml","form_type":"4"}},{"id":1113230,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:35:31.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":399320,"source":{"system":"sec-edgar","filing":"0001628280-25-031022","document":"wk-form4_1749760525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031022/wk-form4_1749760525.xml","form_type":"4"}},{"id":1196985,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T23:40:24.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":321408,"price":7.6033,"value":2443761.4464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":389452,"source":{"system":"sec-edgar","filing":"0001628280-25-013918","document":"wk-form4_1742427618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025013918/wk-form4_1742427618.xml","form_type":"4"}},{"id":1307546,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:19:39.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":22690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":22690,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":22690},"source":{"system":"sec-edgar","filing":"0001520138-25-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000020/ownership.xml","form_type":"4"}},{"id":1307545,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:19:39.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":61600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":61600,"derivative":{"exercise_price":3.36,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":61600},"source":{"system":"sec-edgar","filing":"0001520138-25-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013825000020/ownership.xml","form_type":"4"}},{"id":1483346,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-11T21:46:59.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-24-027709","document":"wk-form4_1718142412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027709/wk-form4_1718142412.xml","form_type":"4"}},{"id":1483345,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:46:59.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":13286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":68044,"source":{"system":"sec-edgar","filing":"0001628280-24-027709","document":"wk-form4_1718142412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027709/wk-form4_1718142412.xml","form_type":"4"}},{"id":1483344,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:46:59.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis"}],"balance_after":54758,"source":{"system":"sec-edgar","filing":"0001628280-24-027709","document":"wk-form4_1718142412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027709/wk-form4_1718142412.xml","form_type":"4"}},{"id":1719805,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-06T21:16:46.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":93500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":93500,"derivative":{"exercise_price":3.01,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":93500},"source":{"system":"sec-edgar","filing":"0001520138-23-000535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000535/ownership.xml","form_type":"4"}},{"id":1801815,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:31:24.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":10061,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-23-029928","document":"wk-form4_1692365476.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029928/wk-form4_1692365476.xml","form_type":"4"}},{"id":1801814,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:31:24.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001628280-23-029928","document":"wk-form4_1692365476.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029928/wk-form4_1692365476.xml","form_type":"4"}},{"id":1801813,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T13:31:24.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":44697,"source":{"system":"sec-edgar","filing":"0001628280-23-029928","document":"wk-form4_1692365476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029928/wk-form4_1692365476.xml","form_type":"4"}},{"id":1932262,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-03T16:22:45.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001628280-23-010323","document":"wf-form4_168053895311193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010323/wf-form4_168053895311193.xml","form_type":"4"}},{"id":1932261,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T16:22:45.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":40060,"source":{"system":"sec-edgar","filing":"0001628280-23-010323","document":"wf-form4_168053895311193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010323/wf-form4_168053895311193.xml","form_type":"4"}},{"id":2052093,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:25:09.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":43578,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68622,"source":{"system":"sec-edgar","filing":"0001520138-23-000059","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013823000059/ownership.xml","form_type":"4"}},{"id":2067101,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:04:03.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001628280-23-000210","document":"wf-form4_167286619186192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000210/wf-form4_167286619186192.xml","form_type":"4"}},{"id":2067100,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:04:03.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":39403,"source":{"system":"sec-edgar","filing":"0001628280-23-000210","document":"wf-form4_167286619186192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000210/wf-form4_167286619186192.xml","form_type":"4"}},{"id":2148655,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-30T20:46:48.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001628280-22-025811","document":"wf-form4_166457078779083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025811/wf-form4_166457078779083.xml","form_type":"4"}},{"id":2148654,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T20:46:48.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":38994,"source":{"system":"sec-edgar","filing":"0001628280-22-025811","document":"wf-form4_166457078779083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025811/wf-form4_166457078779083.xml","form_type":"4"}},{"id":2176062,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:45:46.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":6000,"price":16.4539,"value":98723.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.415 to $16.47. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38660,"source":{"system":"sec-edgar","filing":"0001213900-22-050556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022050556/ownership.xml","form_type":"4"}},{"id":2234090,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-13T20:45:14.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":4637,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001213900-22-032530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022032530/ownership.xml","form_type":"4"}},{"id":2290967,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-25T15:48:48.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":127900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were 25% vested upon grant, with the remaining 75% vesting ratably over a three-year period on each anniversary of the grant date."}],"balance_after":127900,"derivative":{"exercise_price":5.04,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":127900},"source":{"system":"sec-edgar","filing":"0001520138-22-000171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000152013822000171/ownership.xml","form_type":"4"}},{"id":2311113,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T20:48:04.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001213900-22-017501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022017501/ownership.xml","form_type":"4"}},{"id":2454165,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-03T21:45:14.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":743,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001213900-22-000276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022000276/ownership.xml","form_type":"4"}},{"id":2554281,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T20:45:47.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":334,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001213900-21-051142","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021051142/ownership.xml","form_type":"4"}},{"id":2649697,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T20:48:06.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":32660,"source":{"system":"sec-edgar","filing":"0001213900-21-035078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021035078/ownership.xml","form_type":"4"}},{"id":2761112,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T16:38:25.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":32253,"source":{"system":"sec-edgar","filing":"0001213900-21-019878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021019878/ownership.xml","form_type":"4"}},{"id":2808114,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"options","published_at":"2021-03-05T00:47:15.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":99000,"price":13.91,"value":1377090.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date"}],"balance_after":120988,"derivative":{"exercise_price":13.91,"exercise_date":"2020-12-18","expiration_date":"2023-12-18","underlying":"common stock","underlying_shares":99000},"source":{"system":"sec-edgar","filing":"0001703090-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309021000002/primary_doc.xml","form_type":"4"}},{"id":2902239,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-21T01:23:55.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":31714,"source":{"system":"sec-edgar","filing":"0001213900-21-003294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021003294/ownership.xml","form_type":"4"}},{"id":2902238,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-21T01:23:55.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":1183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":30912,"source":{"system":"sec-edgar","filing":"0001213900-21-003294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021003294/ownership.xml","form_type":"4"}},{"id":3001929,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"options","published_at":"2020-10-22T00:18:02.000Z","date":"2020-01-19","kind":"grant","acquired":true,"shares":800,"price":2.8,"value":2240.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations."}],"balance_after":21988,"derivative":{"exercise_price":2.8,"exercise_date":"2020-01-19","expiration_date":"2025-01-19","underlying":"common stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001771317-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000177131720000004/primary_doc.xml","form_type":"5"}},{"id":3001928,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"options","published_at":"2020-10-22T00:18:02.000Z","date":"2019-01-19","kind":"grant","acquired":true,"shares":800,"price":3.75,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On 11/21/2019 a reverse stock split was effected; derivative securities are post-split calculations."}],"balance_after":21188,"derivative":{"exercise_price":3.75,"exercise_date":"2019-01-19","expiration_date":"2024-01-19","underlying":"common stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001771317-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000177131720000004/primary_doc.xml","form_type":"5"}},{"id":3001927,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T00:18:02.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":1600,"price":3.5,"value":5600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On 11/21/2019 a reverse stock split was effected; total shares indicated are post-split."}],"balance_after":25044,"source":{"system":"sec-edgar","filing":"0001771317-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000177131720000004/primary_doc.xml","form_type":"5"}},{"id":3091670,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:33:55.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":29729,"source":{"system":"sec-edgar","filing":"0001213900-20-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/ownership.xml","form_type":"4"}},{"id":3190809,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T12:46:19.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":27792,"source":{"system":"sec-edgar","filing":"0001213900-20-008137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/ownership.xml","form_type":"4"}},{"id":3316330,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T21:30:43.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":25008,"source":{"system":"sec-edgar","filing":"0001213900-20-000382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020000382/ownership.xml","form_type":"4"}},{"id":3401026,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:16:37.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":22924,"source":{"system":"sec-edgar","filing":"0001213900-19-019542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019019542/ownership.xml","form_type":"4"}},{"id":3573981,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T20:20:27.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":14585,"source":{"system":"sec-edgar","filing":"0001213900-19-005244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019005244/ownership.xml","form_type":"4"}},{"id":3673554,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-05T19:49:05.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":200000,"price":0.035,"value":7000.0,"ownership":{"direct":true},"balance_after":450000,"source":{"system":"sec-edgar","filing":"0001703090-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309019000001/primary_doc.xml","form_type":"4"}},{"id":3777832,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-11-01T19:23:28.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":2000000,"price":0.018,"value":36000.0,"ownership":{"direct":true},"balance_after":2548485,"derivative":{"exercise_price":0.018,"exercise_date":"2018-07-02","expiration_date":"2024-07-02","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001703090-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000005/primary_doc.xml","form_type":"4"}},{"id":3777831,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Preferred Stock","published_at":"2018-11-01T19:23:28.000Z","date":"2018-07-03","kind":"grant","acquired":true,"shares":20000,"price":1.5,"value":30000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001703090-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000005/primary_doc.xml","form_type":"4"}},{"id":3791932,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-12T10:07:26.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":12501,"source":{"system":"sec-edgar","filing":"0001213900-18-013822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018013822/ownership.xml","form_type":"4"}},{"id":3843027,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"options","published_at":"2018-08-15T19:48:36.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":100000,"price":0.1,"value":10000.0,"ownership":{"direct":true},"balance_after":548485,"derivative":{"exercise_price":0.1,"exercise_date":"2018-01-19","expiration_date":"2023-01-19","underlying":"common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843026,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-08-15T19:48:36.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":166667,"price":0.15,"value":25000.05,"ownership":{"direct":true},"balance_after":448485,"derivative":{"exercise_price":0.15,"exercise_date":"2018-01-02","expiration_date":"2025-01-01","underlying":"common stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843025,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-08-15T19:48:36.000Z","date":"2017-07-28","kind":"grant","acquired":true,"shares":56818,"price":0.6,"value":34090.8,"ownership":{"direct":true},"balance_after":281818,"derivative":{"exercise_price":0.6,"exercise_date":"2017-07-28","expiration_date":"2022-07-28","underlying":"common stock","underlying_shares":56818},"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843024,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"options","published_at":"2018-08-15T19:48:36.000Z","date":"2016-12-08","kind":"grant","acquired":true,"shares":100000,"price":0.21,"value":21000.0,"ownership":{"direct":true},"balance_after":225000,"derivative":{"exercise_price":0.21,"exercise_date":"2016-12-08","expiration_date":"2021-12-08","underlying":"common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843023,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2018-08-15T19:48:36.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":200000,"price":0.15,"value":30000.0,"ownership":{"direct":true},"balance_after":730303,"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843022,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2018-08-15T19:48:36.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":166667,"price":0.15,"value":25000.05,"ownership":{"direct":true},"balance_after":530303,"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3843021,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2018-08-15T19:48:36.000Z","date":"2017-07-28","kind":"grant","acquired":true,"shares":113636,"price":0.22,"value":24999.92,"ownership":{"direct":true},"balance_after":363636,"source":{"system":"sec-edgar","filing":"0001703090-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580149/000170309018000004/primary_doc.xml","form_type":"4"}},{"id":3874871,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T18:42:35.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":10417,"source":{"system":"sec-edgar","filing":"0001213900-18-008679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008679/ownership.xml","form_type":"4"}},{"id":4100452,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T21:32:21.000Z","date":"2018-01-10","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-18-000485","document":"f4011018lang_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018000485/f4011018lang_optimizerx.xml","form_type":"4"}},{"id":4197706,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T19:08:49.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001213900-17-010181","document":"f4092917lang_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017010181/f4092917lang_optimizerx.xml","form_type":"4"}},{"id":4269235,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T20:46:46.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001213900-17-007052","document":"f4063017lang_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017007052/f4063017lang_optimizerx.xml","form_type":"4"}},{"id":4356781,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39646,"kind":"person","name":"Lang James Paul","position":1,"cik":"0001703090","reported_name":"Lang James Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-06T20:07:03.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001213900-17-003442","document":"f4033117lang_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017003442/f4033117lang_optimizerx.xml","form_type":"4"}}]}